Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (UNAUDITED)

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (UNAUDITED) - 3 months ended Mar. 31, 2018 - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2017 234,076,907      
Beginning balance, value at Dec. 31, 2017 $ 234,077 $ 108,000,923 $ (110,109,000) $ (1,874,000)
Common stock issued on exercise of warrants and options, shares 1,345,710      
Common stock issued on exercise of warrants and options, value $ 1,346 69,654   71,000
Fair value of common stock issued on conversion of notes payable, shares issued 1,278,750      
Fair value of common stock issued on conversion of notes payable, value $ 1,279 97,721   99,000
Fair value of warrants and beneficial conversion feature of issued convertible notes   245,000   245,000
Fair value of options and warrants issued as compensation   143,000   143,000
Common stock issued for services, shares 50,000      
Common stock issued for services, value $ 50 11,950   12,000
Net loss     (700,000) (700,000)
Ending balance, shares at Mar. 31, 2018 236,751,367      
Ending balance, value at Mar. 31, 2018 $ 236,752 $ 108,568,248 $ (110,809,000) $ (2,004,000)